Intrinsic Value of S&P & Nasdaq Contact Us

Cognition Therapeutics, Inc. CGTX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
54/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — CGTX

Cognition Therapeutics, Inc. (CGTX) has a market capitalization of $71.77M and trades at $0.98. The 52-week range is 0.222-3.83.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3, Earnings Per Share (EPS) of $-0.32.

The stock has a beta of 1.40, operates in the Healthcare sector.

Trading Data
Current Price$0.98
52-Week Range0.222-3.83
Volume886.12K
Avg Volume (30D)1.06M
Market Cap$71.77M
Beta (1Y)1.40
Company
IPO Date2021-10-08
Employees25
CEOLisa Ricciardi
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS19243B1026
CUSIP19243B102
Income (Latest Year)
Gross Profit$-228K
EBITDA$-47.8M
Operating Income$-47.8M
Net Income$-23.49M
EPS$-0.32
EPS Diluted$-0.32
Shares Outstanding$72.77M
Balance Sheet (Latest Year)
Total Assets$48.39M
Current Assets$47.99M
Cash & ST Investments$36.81M
Total Liabilities$14.12M
Total Debt$638K
Net Debt$-36.17M
Total Equity$34.27M
Debt / Equity0.02
Valuation Ratios
P/E Ratio-3
P/B Ratio2.09
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message